TRi-1

Overview

TRi-1 is a potent, specific and irreversible inhibitor of cytosolic thioredoxin reductase 1 (TXNRD1) , with an IC 50 of 12 nM. TRi-1 has little mitochondrial toxicity for anticancer therapy.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > JNK | Products > Signaling Pathways > p38 MAPK

Product Information

• Catalog No.: HY-125006
• CAS No.: 246020-68-8
• Molecular Formula: C12H9ClN2O5S
• Molecular Weight: 328.73
• Purity: 99.69%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.08 mg/mL (6.33 mM); Clear solution
• Availability: In-stock

Source

Original product source